Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.
Arrondeau J, Huillard O, Tlemsani C, Cessot A, Boudou-Rouquette P, Blanchet B, Thomas-Schoemann A, Vidal M, Tigaud JM, Durand JP, Alexandre J, Goldwasser F. Arrondeau J, et al. Among authors: blanchet b. Expert Opin Investig Drugs. 2015 May;24(5):673-87. doi: 10.1517/13543784.2015.1005736. Epub 2015 Jan 20. Expert Opin Investig Drugs. 2015. PMID: 25599887 Review.
Toxicity of sorafenib: clinical and molecular aspects.
Blanchet B, Billemont B, Barete S, Garrigue H, Cabanes L, Coriat R, Francès C, Knebelmann B, Goldwasser F. Blanchet B, et al. Expert Opin Drug Saf. 2010 Mar;9(2):275-87. doi: 10.1517/14740330903510608. Expert Opin Drug Saf. 2010. PMID: 20078249 Review.
Treatment of bevacizumab-induced hypertension by amlodipine.
Mir O, Coriat R, Ropert S, Cabanes L, Blanchet B, Camps S, Billemont B, Knebelmann B, Goldwasser F. Mir O, et al. Among authors: blanchet b. Invest New Drugs. 2012 Apr;30(2):702-7. doi: 10.1007/s10637-010-9549-5. Epub 2010 Sep 29. Invest New Drugs. 2012. PMID: 20878444
More on aprepitant for erlotinib-induced pruritus.
Mir O, Blanchet B, Goldwasser F. Mir O, et al. Among authors: blanchet b. N Engl J Med. 2011 Feb 3;364(5):487. doi: 10.1056/NEJMc1013027. N Engl J Med. 2011. PMID: 21288111 No abstract available.
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.
Tod M, Mir O, Bancelin N, Coriat R, Thomas-Schoemann A, Taieb F, Boudou-Rouquette P, Ropert S, Michels J, Abbas H, Durand JP, Dauphin A, Vidal M, Goldwasser F, Blanchet B. Tod M, et al. Among authors: blanchet b. Pharm Res. 2011 Dec;28(12):3199-207. doi: 10.1007/s11095-011-0499-1. Epub 2011 Jun 21. Pharm Res. 2011. PMID: 21691893
153 results